John Townsend - Jul 12, 2021 Form 3 Insider Report for Unicycive Therapeutics, Inc. (UNCY)

Role
Chief Financial Officer
Signature
/s/ John Townsend
Stock symbol
UNCY
Transactions as of
Jul 12, 2021
Transactions value $
$0
Form type
3
Date filed
7/12/2021, 05:11 PM
Next filing
Jul 26, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding UNCY Employee Stock Option (right to buy) Jul 12, 2021 Common Stock 23.3K $7.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the stock options vest on March 1, 2022, and the remaining seventy-five percent (75%) of the stock options vest in successive equal monthly installments over the following thirty-six (36) months, until the options become fully vested on March 1, 2025.